Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Georges Adunlin

Using Quality-Adjusted Progression-Free Survival as an Outcome Measure to Assess the Benefits of Cancer Drugs in Randomized-Controlled Trials: Case of the BOLERO-2 Trial

Breast Cancer Research and Treatment

Cancer Research

Oncology

2014

English

COVID-19: How Can Rural Community Pharmacies Respond to the Outbreak?

Journal of Rural Health

English

Related publications

P1.15-29 Impact of Radiation Therapy Quality Assurance on Progression-Free and Overall Survival in Randomized Trials of Lung Cancer

Journal of Thoracic Oncology

English

Using Routinely Recorded Data in the UK to Assess Outcomes in a Randomised Controlled Trial: The Trials of Access

English

Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs

JAMA network open

Medicine

2019

English

Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail the Last Barrier?

International Journal of Cancer

Cancer Research

Oncology

2018

English

Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)

PLoS ONE

Multidisciplinary

2013

English

Evolving Options for the Treatment of Metastatic Breast Cancer: Progression-Free Survival as an Endpoint

Cancer Treatment Reviews

English

Use of Continuous Glucose Monitoring as an Outcome Measure in Clinical Trials

Diabetes Technology and Therapeutics

Medicine

Endocrinology

Medical Laboratory Technology

Metabolism

Diabetes

2012

English

TRIal to Slow the Progression of Diabetes (TRIPOD): Study Protocol for a Randomized Controlled Trial Using Wireless Technology and Incentives

English

Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Georges Adunlin

Using Quality-Adjusted Progression-Free Survival as an Outcome Measure to Assess the Benefits of Cancer Drugs in Randomized-Controlled Trials: Case of the BOLERO-2 Trial

COVID-19: How Can Rural Community Pharmacies Respond to the Outbreak?

Related publications

P1.15-29 Impact of Radiation Therapy Quality Assurance on Progression-Free and Overall Survival in Randomized Trials of Lung Cancer

Using Routinely Recorded Data in the UK to Assess Outcomes in a Randomised Controlled Trial: The Trials of Access

Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs

Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail the Last Barrier?

Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)

Evolving Options for the Treatment of Metastatic Breast Cancer: Progression-Free Survival as an Endpoint

Use of Continuous Glucose Monitoring as an Outcome Measure in Clinical Trials

TRIal to Slow the Progression of Diabetes (TRIPOD): Study Protocol for a Randomized Controlled Trial Using Wireless Technology and Incentives

Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare